Related Experiment Videos
Management of postmenopausal osteoporosis
Frederick T Murphy1, Alan J Kivitz, Earl E Sands
1Center for Clinical Research, Altoona Arthritis and Osteoporosis Center, Meadowbrook Plaza, 1125 Old Route 220 North, Duncansville, PA 16635, USA. ftmurphy@pol.net
The Journal of the American Osteopathic Association
|November 19, 2003
Summary
Postmenopausal osteoporosis causes fractures in 1.5 million US women annually, increasing mortality and healthcare costs. Early intervention with therapies is crucial for preventing initial and subsequent fractures.
Area of Science:
- Bone health and metabolic disorders
- Geriatric medicine and public health
Background:
- Postmenopausal osteoporosis significantly impacts morbidity, mortality, quality of life, and healthcare expenditure.
- Approximately 1.5 million women in the U.S. experience osteoporosis-related fractures yearly, with vertebral fractures being most common.
- A prior fracture increases the risk of a subsequent fracture fivefold within one year.
Purpose of the Study:
- To review currently approved therapeutic modalities for the prevention and treatment of postmenopausal osteoporosis.
- To emphasize the importance of early detection and intervention in managing osteoporosis.
Main Methods:
- Review of current literature on postmenopausal osteoporosis management.
- Analysis of approved therapeutic agents and their roles in prevention and treatment.
Main Results:
- The management of osteoporosis involves multiple therapeutic modalities.
- Early implementation of therapies, alongside lifestyle interventions, is recommended to prevent fractures.
- Various therapeutic agents are available for osteoporosis management.
Conclusions:
- Comprehensive management strategies are essential for addressing postmenopausal osteoporosis.
- Timely and appropriate therapeutic interventions can mitigate the risks associated with osteoporosis-related fractures.
- Continued research and development of therapies are vital for improving patient outcomes.